Our aim is to assess the long-term health effects and cost-effectiveness of PSA screening with S3M used as a reflex test above a PSA of 1, 1.5 or 2 ng/mL compared with no prostate cancer screening or PSA screening alone. Here, KLK3 is linked to Familial prostate cancer.